Literature DB >> 11280787

Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.

G Bellone1, A Carbone, N Sibona, O Bosco, D Tibaudi, C Smirne, T Martone, C Gramigni, M Camandona, G Emanuelli, U Rodeck.   

Abstract

Multiple genetic aberrations contribute to the development of biologically aggressive, clinically malignant colorectal carcinomas (CRCs). Some of these have been linked to inappropriate signaling through the tyrosine kinase moieties of growth factor receptors. We have described previously (G. Bellone et al., J. Cell. Physiol., 172: 1-11, 1997) that human CRCs overexpress both the receptor tyrosine kinase c-kit and its ligand, stem cell factor (SCF), relative to normal mucosa cells, thus establishing an autocrine c-kit-mediated loop. In addition, we noted that exogenous SCF contributes to anchorage-independent growth of HT-29 colon carcinoma cells in semisolid medium. Here, we investigated possible roles of the c-kit/SCF autocrine/paracrine system in survival and invasive capacity of DLD-1 colon carcinoma cells. We report that SCF was required for migration and invasion of DLD-1 cells through reconstituted basement membranes (Matrigel) and up-regulated gelatinase (matrix metalloproteinase-9) activity in DLD-1 cells. Furthermore, we describe that SCF supported survival of DLD-1 cells in growth factor-deprived conditions. These results suggest multiple roles of c-kit activation in support of the malignant phenotype of DLD-1 cells related to growth, survival, migration, and invasive potential.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280787

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor (GIST).

Authors:  Marcovalerio Melis; Eugene A Choi; Robert Anders; Peter Christiansen; Alessandro Fichera
Journal:  Int J Colorectal Dis       Date:  2006-04-26       Impact factor: 2.571

2.  Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors.

Authors:  Anna Maria Almerico; Marco Tutone; Antonino Lauria
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

3.  Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.

Authors:  Sivapriya Ponnurangam; David Standing; Parthasarathy Rangarajan; Dharmalingam Subramaniam
Journal:  Mol Cancer Ther       Date:  2013-02-20       Impact factor: 6.261

4.  Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.

Authors:  Jan Friederichs; Claus W H von Weyhern; Robert Rosenberg; Dietrich Doll; Raymonde Busch; Florian Lordick; Jörg Rüdiger Siewert; Mario Sarbia
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

5.  A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.

Authors:  Ana Preto; Cátia Moutinho; Sérgia Velho; Carla Oliveira; Ana Paula Rebocho; Joana Figueiredo; Paula Soares; José Manuel Lopes; Raquel Seruca
Journal:  Virchows Arch       Date:  2007-05-09       Impact factor: 4.064

6.  KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells.

Authors:  Shu Yang; Wen-shuai Li; Fang Dong; Hai-mei Sun; Bo Wu; Jun Tan; Wan-jing Zou; De-shan Zhou
Journal:  J Cell Mol Med       Date:  2014-09-12       Impact factor: 5.310

7.  A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells.

Authors:  Alejandro Schcolnik-Cabrera; Guadalupe Dominguez-Gómez; Alma Chávez-Blanco; Marisol Ramírez-Yautentzi; Rocío Morales-Bárcenas; José Chávez-Díaz; Lucía Taja-Chayeb; Alfonso Dueáas-González
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

8.  STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1.

Authors:  Toufeng Jin; Hajime Nakatani; Takahiro Taguchi; Takumi Nakano; Takehiro Okabayashi; Takeki Sugimoto; Michiya Kobayashi; Keijiro Araki
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

9.  Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway.

Authors:  Akira Yasuda; Hirozumi Sawai; Hiroki Takahashi; Nobuo Ochi; Yoichi Matsuo; Hitoshi Funahashi; Mikinori Sato; Yuji Okada; Hiromitsu Takeyama; Tadao Manabe
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

10.  Study of the role of "gatekeeper" mutations V654A and T670I of c-kit kinase in the interaction with inhibitors by means mixed molecular dynamics/docking approach.

Authors:  Marco Tutone; Antonino Lauria; Anna Maria Almerico
Journal:  Bioinformation       Date:  2011-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.